Kulia Peruszo
Chau Paulo, S.P. (Folhapress)
The Ministry of Health says the NPH will change NPH for many years after six years of insertion of Konitech (National Commission for Technology) to treat type 1 diabetes.
In spite of premature, there are reports of patients who cannot access the inputs required for proper treatment of the disease, even if they get or win through the SUS (Unifted Health System). In the private network, spending only for the required entries can be between $ 2,000 and $ 5,000 depending on the type of treatment for the patient, and does not specify the costs of consultation with experts.
In Brazil, Article 11,347 of September 2006 determines that public activity is available in the public network of insulin. Apart from them, it is also mandatory to provide strips to measuring blood glucose, needles, throwing and syringe.
There is no adherence to or performing medication for every state of the long -term insulin that comes with public services this month. “States have their own medical norms and we have this big difference between the states of the federation,” says health lawyer Isabel Goreb.
So far, the Ministry of Health says that only six states have requested insulin to submit: Esprido Santo, Paraba, Piava, Rio Grande Do Norde and Chau Paulo; Except for the pending request from the state of Para.
There is no obligation to be available on the public network such as glucose sensors and insulin pumps, and there are also advanced technologies. But Coreb explains that the states and municipalities have autonomy to determine whether or not the distribution of glucose sensors.
It is in this context that the judiciary comes to support patients who do not have access to specific inputs to survival with type 1 diabetes, and the lack of health facilities or is available. “Today, we have been able to order all the technologies and medicines available to treat diabetes in the country and, as a result, is recorded with Anvisa,” the lawyer says.
But it is not anyone who can find this feature. In the case of the request of the inputs that are not obliged by the SUS, the patient must first test all the inputs available and prove that they are not effective in treatment. In addition, you should also prove that your family income is not adequate to pay for your own treatment.
The total case may take up to three years, but from the entry of the order to obtain the order to begin inputs before the final verdict is two months away.
If the patient gets the right to obtain the necessary entries through the government, the result is permanent. “We will decide on judges, legal experts, not health,” the lawyer says.
In practice, the receipt is very complicated. Digital Media Analyst Tais Matias, 33, diagnosed with type 1 diabetes at the age of 14, fought for his rights and faced problems with the disease.
Temanies, she was unable to buy the costs of the drugs she needed and could develop diabetic retinopathy, which can lead to vision loss. In 2023, the court managed the favorable concept of obtaining insulin, blood glucose sensor and i-port, which was a device for using insulin without harming the skin, because it developed Lipodistrophy (distribution of fat in fat) injections.
“Only then, I have never received all the entries when I go to the pharmacy to search. I only get one or two. You have to get more.” “Usually they provide me with only long -term insulin.” That is, Tais does not even get what is predicted by federal law, such as lancets and needles.
The solution you found is to file a court order to obtain the value of the entries you use. She receives money in her personal account, buy medicines and then send the proof of using money.
Solnge Dravasos, Vice President of the Brazilian Diabetes Association, said, “We have a situation in the country today, which spends a lot of treatment for avoidable complications, especially in a low -income population.” He notes that a person with financial resources to endure treatment is 25 years and better than the general system.
The bill (PL) 2,687/2022 aimed at comparing the disease with a disabled may help to expand the public policies that guarantee the access of the population for effective treatment. However, in January 2025, he was vetoed by President Lula.
“There is no benefit for this, we are the role we want. This is an investment with a warranty social and financial income,” says Travasos. He says there are cases that depend on high cost therapy and that if it is not provided, this person will need more treatment with complications.
In a statement, the President of the Brazilian Endocrinology and Metabology Society said, “These laws guarantee the social security that promotes essential and essential treatments and equal opportunities for the health of these laws.
Public Health Program supports Umane, a Civil Association, which aims to help with initiatives aimed at improving health
[ad_2]
Source link
